hemispherx biopharma inc (HEB:NYSE Amex)
William A. Carter M.D.
Chairman, Chief Executive Officer, President, Chief Scientific Officer, Chairman of Executive Committee, Member of Strategic Planning Committee and Member of Disclosure Controls Committee, Hemispherx Biopharma, Inc.
|Age||Total Calculated Compensation||This person is connected to 6 board members in 1 different organizations across 1 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. William A. Carter, M.D. has been the Chairman, Chief Executive Officer, President and Chief Scientific Officer of Hemispherx Biopharma Inc. since January 1992, July 1993, December 2011 and May 1989 respectively. Dr. Carter joined Hemispherx Biopharma Inc., in 1978 and served as its Chairman from 1987 to 1988 and President from April 1995 to November 2006. Dr. Carter is co-inventor of Ampligen. Dr. Carter received the first FDA approval to initiate clinical trials ...
One Penn CenterPhone: 215-988-0080
Philadelphia, Pennsylvania 19103
Board Members Memberships*
Chairman, Chief Executive Officer, President, Chief Scientific Officer, Chairman of Executive Committee, Member of Strategic Planning Committee and Member of Disclosure Controls Committee
Johns Hopkins University
|Frank Mathias||Chief Executive Officer and Member of Executive Board|
|Brenton L. Saunders J.D.||Chief Executive Officer, President and Director|
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|Edward M. Kaye M.D., Ph.D.||Interim Chief Executive Officer, Chief Medical Officer and Senior Vice President|
Sarepta Therapeutics, Inc.
|$399.0K||Compensation as of Fiscal Year 2014.|